Global Biotechnology Industry

The global biotechnology market is ready to expand at a CAGR of 12. 4% from 2016 to 2025. Some of the dominant players in the market include Amgen Inc., Novartis AG, and Biogen Idec, Inc. The industry can be characterized by increasing R&D activities and reduced cost of DNA sequencing, which are critical factors travelling the overall regarding the industry. Furthermore, the dwindling supply of natural assets and the developing demand for biofuels are expected to boost the industry’s revenue progress.

North America is likewise expected to lead the global biotechnology market during the forecast period. This region can be dominated by presence of major players in the field, and has substantial healthcare expense and R&D spending. Additionally , the growing awareness of biotechnology is maximizing the market’s growth in this region. Many companies in the area are establishing advanced items to meet the needs on this industry. Additionally , the presence of key element players in the region will support the market’s expansion.

Inflazome, an Irish biotechnology company, is aiming to produce inflammasome blockers and is required to be the key player in the Global Biotechnology Market simply by 2020. Other key players in the market involve Johnson & Johnson, Celgene Corporation, Amgen, Inc., and Vertex Pharmaceutical drugs, Inc. Small companies such as Seagen Inc. are also poised to prosper in this industry.

Leave a Comment

Your email address will not be published. Required fields are marked *